- Home
- NVNO vs SRZN Comparison
NVNO vs SRZN Comparison
Compare NVNO & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- SRZN
- Stock Information
- Founded
- NVNO 1987
- SRZN 2015
- Country
- NVNO United States
- SRZN United States
- Employees
- NVNO N/A
- SRZN N/A
- Industry
- NVNO Medical/Dental Instruments
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- NVNO Health Care
- SRZN Health Care
- Exchange
- NVNO Nasdaq
- SRZN Nasdaq
- Market Cap
- NVNO 78.7M
- SRZN 72.8M
- IPO Year
- NVNO N/A
- SRZN N/A
- Fundamental
- Price
- NVNO $4.05
- SRZN $10.00
- Analyst Decision
- NVNO
- SRZN Strong Buy
- Analyst Count
- NVNO 0
- SRZN 2
- Target Price
- NVNO N/A
- SRZN $38.50
- AVG Volume (30 Days)
- NVNO 135.7K
- SRZN 15.0K
- Earning Date
- NVNO 07-30-2025
- SRZN 08-11-2025
- Dividend Yield
- NVNO N/A
- SRZN N/A
- EPS Growth
- NVNO N/A
- SRZN N/A
- EPS
- NVNO N/A
- SRZN N/A
- Revenue
- NVNO N/A
- SRZN $11,638,000.00
- Revenue This Year
- NVNO N/A
- SRZN N/A
- Revenue Next Year
- NVNO $409.09
- SRZN N/A
- P/E Ratio
- NVNO N/A
- SRZN N/A
- Revenue Growth
- NVNO N/A
- SRZN N/A
- 52 Week Low
- NVNO $2.03
- SRZN $5.90
- 52 Week High
- NVNO $6.48
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- NVNO 54.46
- SRZN 61.67
- Support Level
- NVNO $4.19
- SRZN $9.15
- Resistance Level
- NVNO $4.52
- SRZN $10.05
- Average True Range (ATR)
- NVNO 0.39
- SRZN 0.53
- MACD
- NVNO -0.01
- SRZN 0.20
- Stochastic Oscillator
- NVNO 47.29
- SRZN 93.33
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).